Study finds common antibiotic azithromycin carries heart risk
Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a "Z-pack." The study found a 2.5-fold higher risk of death from cardiovascular death in the first five ...
Medications
5 hours ago |
not rated yet |
0
|
In drug-approval race, US FDA ahead of Canada, Europe
The U.S. Food and Drug Administration (FDA) generally approves drug therapies faster and earlier than its counterparts in Canada and Europe, according to a new study by Yale School of Medicine researchers. The study counters ...
Medications
5 hours ago |
not rated yet |
0
|
'Last resort' antibiotics increasingly used to fight multidrug-resistant bugs
Multidrug-resistant pathogens are becoming more frequent, and the few "last resort" treatments available for infections with these bacteria have also shown an increase in use in recent years, according to a study published ...
Medications
5 hours ago |
not rated yet |
0
Too many drugs for many older patients
Older patients are increasingly prescribed multiple drugs that, when combined, can lead to negative side effects and poor health outcomes. A new Cochrane Library evidence review reveals that little is kno ...
Medications
12 hours ago |
not rated yet |
0
Plavix's new generic status could be boon for patients
(HealthDay) -- The blockbuster drug Plavix (clopidogrel), used to prevent clotting in some heart patients, will go off patent in the United States on Thursday, making it considerably more affordable.
Medications
May 15, 2012 |
not rated yet |
0
Reducing off-label use of antipsychotic medications may save money
Reducing the non-FDA-approved use of antipsychotic drugs may be a way to save money while having little effect on patient care, according to a Penn State College of Medicine study.
Medications
May 15, 2012 |
5 / 5 (1) |
1
FDA issues multiple sclerosis drug alert
(HealthDay) -- The multiple sclerosis drug Gilenya (fingolimod) should not be given to patients with certain pre-existing or recent heart conditions or stroke, or those taking certain medications to correct ...
Medications
May 14, 2012 |
not rated yet |
0
ECO: New weight loss drug effective in advanced obesity
(HealthDay) -- A new combination treatment of controlled-release phentermine/topiramate (PHEN/TPM CR) leads to significantly greater weight loss than a placebo even in individuals with significant obesity-related ...
Medications
May 14, 2012 |
not rated yet |
0
Only half of meds taken by kids have 'adequate' safety info: study
(HealthDay) -- About half of medications used in children have little or no label information about drug effectiveness, safety or dosing in children, new research finds.
Medications
May 11, 2012 |
not rated yet |
0
FDA advisers recommend approving weight loss drug
(AP) -- Advisers to government health regulators on Thursday recommended that that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over ...
Medications
May 10, 2012 |
1 / 5 (1) |
0
French trial opens in diabetes-diet drug scandal
(AP) -- The first French trial has begun over a diabetes drug that was also used to lose weight and is suspected in the deaths of at least 500 people.
Medications
May 14, 2012 |
not rated yet |
0
Indian expert panel to probe drugs regulator
India's Health Ministry said Friday it had set up an expert panel to review the operations of its drug regulatory agency, accused of colluding with pharmaceutical firms to approve drugs without trials.
Medications
May 11, 2012 |
not rated yet |
0
India probes charges of violations by drugs regulator
India's Health Ministry said Thursday it was examining charges that the government's top drug regulatory agency had colluded with pharmaceutical firms to approve drugs without proper clinical trials.
Medications
May 10, 2012 |
not rated yet |
0
GSK launches hostile $2.6 bn bid for Human Genome Sciences
British drugmaker GlaxoSmithKline on Wednesday said it had gone hostile over its $2.6 billion (2.0 billion-euro) takeover bid for US research partner Human Genome Sciences Inc.
Medications
May 09, 2012 |
not rated yet |
0
- Pages: 1
